Spyre Therapeutics
0 followers
SYRE
Performance
About Spyre Therapeutics
Spyre Therapeutics is a biotechnology company developing next-generation antibodies engineered for prolonged activity to treat inflammatory bowel disease and other immune-mediated conditions. Their pipeline targets validated mechanisms in gastrointestinal and rheumatic diseases, with the aim of delivering monotherapies or combination therapies that offer uncompromising efficacy and convenience. The company emphasizes patient-focused commitments and seeks to transform the lives of patients and caregivers through innovative antibody therapies in the IBD space and related immune-mediated diseases.